Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
07/2000
07/04/2000US6083903 Boronic ester and acid compounds, synthesis and uses
06/2000
06/29/2000WO2000037444A1 Compounds useful in the treatment of inflammatory diseases
06/29/2000WO2000037429A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
06/29/2000WO2000002887A3 Ligands for metals and metal-catalyzed processes
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/29/2000CA2355630A1 Compounds useful in the treatment of inflammatory diseases
06/28/2000EP1012134A1 Quaternary ammonium phosphate compound and method of preparing the same
06/28/2000EP1012131A1 Enantioselective reduction of ketones with a silane agent/metal compound/chiral ligand system
06/28/2000CN1053895C Substd. sulfonic acid amide, preparation process and pharmaceutical composition of same
06/28/2000CN1053886C Naphthyl compounds, intermediates and their preparing method and use
06/27/2000US6080865 A polymerization catalysts in the production of polyurethanes; a reaction product of the 2-methylglutaronitrile with hydrogen
06/27/2000US6080863 Activating a hydrogenation catalyst in the presence of hydrogen and under activation conditions including heating and pressurization
06/27/2000US6080860 Urea compound where one of the urea nitrogens is part of an (un)substituted 5 or 6 membered ring and/or the other urea nitrogen is substituted with a 2-cyano-4,5-dialkoxyphenyl group; reacting with electrophile to form a leaving group
06/27/2000CA2017193C N-(aryloxyalkyl)heteroarylpiperidines and-heteroarylpiperazines, a pro cess for their preparation and their use as medicaments
06/22/2000WO2000035892A1 Piperazine ethylamide derivatives with 5-ht1a receptor activity
06/22/2000WO2000035882A1 1,2,3,4-tetrahydronaphthalenes and their pharmaceutical use
06/22/2000WO2000035879A1 3-phenyl-2,6-dioxopiperidin-3-yl propionamide derivatives and method for preparing same
06/22/2000WO2000035864A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
06/22/2000WO2000035860A2 Acyl isothiocyanate resins and their use in solid-supported synthesis of guanidines
06/22/2000WO2000035859A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
06/22/2000WO2000035858A1 Phenylglycine derivatives
06/22/2000WO2000035855A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
06/22/2000WO2000035442A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000WO2000035436A2 Treatment of arthritis with mek inhibitors
06/22/2000WO2000035435A1 Use of a mek inhibitor for preventing transplant rejection
06/22/2000WO2000004954A3 Novel urokinase inhibitors
06/22/2000CA2369115A1 3-phenyl-2,6-dioxopiperidin-3-yl propionamide derivatives and method for preparing same
06/22/2000CA2355890A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
06/22/2000CA2355161A1 Biphenyl and biphenyl-analogous compounds as integrin antagonists
06/22/2000CA2353151A1 Substituted aryl and heteroaryl derivatives, the preparation thereof and their use as medicaments
06/22/2000CA2351860A1 Piperazine ethylamide derivatives with 5-ht1a receptor activity
06/22/2000CA2351464A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
06/22/2000CA2346684A1 Use of a mek inhibitor for preventing transplant rejection
06/22/2000CA2346448A1 Treatment of arthritis with mek inhibitors
06/21/2000EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
06/21/2000EP1009736A1 Malonic acid based matrix metalloproteinase inhibitors
06/21/2000EP1009732A2 1-amino-alkylcyclohexane nmda receptor antagonists
06/21/2000EP0638073B1 1-piperazino-1,2-dihydroindene derivatives
06/21/2000CN1053666C Benzoheterocylic compounds and process for preparing medicated salt thereof
06/21/2000CN1053657C Didepside phthaleins based internal parasite compositions, novel didepside phthaleins and preparation process thereof
06/21/2000CN1053571C Application of proliferation in preparation of medicine for inhibiting smooth muscle cell and restinosis
06/20/2000US6077698 Nonpolymeric compound including at least two aryl ketones and one or more sulfonate, phosphonate, and carboxylate groups; for surface treatments and immobilization in aqueous systems
06/15/2000WO2000034268A1 Thiourea inhibitors of herpes viruses
06/15/2000WO2000034238A1 Thiourea inhibitors of herpes viruses
06/15/2000WO2000034237A2 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
06/15/2000WO2000034231A1 Molecular scaffolds acting as templates comprising carbamate linkages
06/15/2000WO2000012454A9 Novel polycationic lipids
06/15/2000WO2000006531A3 Nitric esters and nitrate salts of specific drugs
06/15/2000CA2353462A1 Molecular scaffolds acting as templates comprising carbamate linkages
06/15/2000CA2351403A1 Thiourea inhibitors of herpes viruses
06/15/2000CA2350996A1 Thiourea inhibitors of herpes viruses
06/15/2000CA2350899A1 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
06/14/2000EP1008592A2 Cyclic amide derivatives which inhibit cathepsin K
06/14/2000EP1008346A1 NF-$g(k)B INHIBITORS CONTAINING AS THE ACTIVE INGREDIENT PHENYLMETHYL BENZOQUINONE
06/14/2000EP1007033A1 Lymphocyte function antigen-1 antagonists
06/14/2000EP0823892B1 Tetralines bearing a phenyl substituant on the aromatic ring and their use in the treatment of epilepsy, stroke and brain or spinal trauma
06/14/2000EP0777645B1 Oxime ethers and their use as pesticides
06/14/2000CN1256272A Preparation of N-formyl morpholine, N-formyl piperazine and their homologues
06/14/2000CN1053441C Compound with 1-(aryl china olefine)-4-(aryl methyl) piperazine structure, its preparation process and medicine containing the compound thereof
06/13/2000US6075146 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceuticals
06/13/2000US6075026 Certain substituted 1-aryl-3-piperazin-1'-yl propanones
06/13/2000CA1341024C Benzo-fused cycloalkane and oxa- and thia-, cycloalkane trans-1, 2-diamine derivatives
06/08/2000WO2000032583A1 Antitumor dibenzofluorene derivatives
06/08/2000WO2000032582A1 Benzamide derivatives and their use as apob-100 secretion inhibitors
06/08/2000WO2000032570A1 Hydrazine derivatives
06/08/2000WO2000032569A2 Alpha-sulfin- and alpha-sulfonamino acid amides
06/08/2000CA2353394A1 Benzamide derivatives and their use as apob-100 secretion inhibitors
06/08/2000CA2352878A1 Antitumor dibenzofluorene derivatives
06/08/2000CA2351321A1 Hydrazine derivatives
06/07/2000EP1006153A1 Cationic amino-dianthraquinones, use thereof, dyeing compositions containing them and dyeing processes
06/07/2000EP1005448A2 Novel inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis
06/07/2000EP1005446A1 N-aroylphenylalanine derivatives
06/07/2000EP1005445A1 N-alkanoylphenylalanine derivatives
06/07/2000CN1255497A Method for preparing pyrazo [4,3-d] pyrimidine-7-one and its intermediate
06/06/2000US6071970 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
06/06/2000US6071920 Bind to 5ht 1a receptors for treating disorders of the lower urinary tract; cns disorders; anxiolytic agents; antidepressants; hypotensive agents; sleep and eating disorders
06/06/2000US6071915 Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
06/06/2000US6071895 Polar-substituted hydrocarbons
06/06/2000US6071510 Modified amino acids and compositions comprising the same for delivering active agents
06/06/2000CA2015033C Tertiary alkyl functionalized piperazine derivatives
06/02/2000WO2000031030A1 Bifunctional photoinitiators suitable for photopolymerization and photopolymerizable systems containing the same
06/02/2000WO2000031021A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS
06/02/2000WO2000030444A1 Cationic liposomes for gene transfer
06/02/2000CA2351692A1 Inhibitors of production and/or secretion of amyloid-.beta. protein
05/2000
05/31/2000EP1004306A2 Estrogen agonists/antagonists
05/31/2000EP1003728A1 2- 3- 4-(2-t-butyl-6- trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto pyrimidin-4-ol-fumarate
05/31/2000EP1003714A1 Aromatic amides, their preparation process and their use as pesticides
05/31/2000EP1003540A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
05/31/2000EP1003514A1 Cyclic amine modulators of chemokine receptor activity
05/31/2000EP1003495A1 Pharmaceutical compounds
05/31/2000EP1003373A1 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
05/31/2000EP0882016B1 Alkylated styrenes as prodrugs to cox-2 inhibitors
05/31/2000EP0633775B1 Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor
05/31/2000CN1255119A Protease inhibitors
05/31/2000CN1254596A Process for preparing composition to kill internal parasites
05/31/2000CN1052977C Method for preparing moclobemide
05/30/2000US6069247 Reacting an acetylenecarboxy amide and an aryl or heterocyclyl halide or a group enhancing the electrophilicity of the atom to which it is attached for displacement; using a palladium compound catalyst, a base and an acid
05/30/2000US6069176 Phenylethanolamine compounds with a beta-3 adrenergic receptor stimulating effect, use as a therapy for urinary incontinence
05/30/2000US6069175 Administering to a mammal in need a therapeutically effective amount of a member selected from the 4-hydroxy tamoxifen, raloxifene, toremifene, centchroman, idoxifene to treat atherosclerosis
05/30/2000US6069143 Anticoagulants